60 related articles for article (PubMed ID: 38173030)
1. Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma.
Shi B; Ge F; Cai L; Yang Y; Guo X; Wu R; Fan Z; Cao B; Wang N; Si Y; Lin X; Dong W; Sun H
Front Immunol; 2023; 14():1247288. PubMed ID: 38022677
[TBL] [Abstract][Full Text] [Related]
2. WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy.
Cheng X; Liu Z; Chang H; Liang W; Li P; Gao Y
Eur J Med Res; 2024 Jan; 29(1):13. PubMed ID: 38173030
[TBL] [Abstract][Full Text] [Related]
3. ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.
Cheng X; Liu Z; Liang W; Zhu Q; Wang C; Wang H; Zhang J; Li P; Gao Y
Int J Biochem Cell Biol; 2023 May; 158():106409. PubMed ID: 36997057
[TBL] [Abstract][Full Text] [Related]
4. Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.
Dayebgadoh G; Sardiu ME; Florens L; Washburn MP
J Proteome Res; 2019 Sep; 18(9):3479-3491. PubMed ID: 31353912
[TBL] [Abstract][Full Text] [Related]
5. The role of WDR76 protein in human diseases.
Yang J; Wang F; Chen B
Bosn J Basic Med Sci; 2021 Oct; 21(5):528-534. PubMed ID: 33714259
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma.
Li J; Guo Q; Xing R
BMC Cancer; 2023 Aug; 23(1):727. PubMed ID: 37543576
[TBL] [Abstract][Full Text] [Related]
7. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
8. ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway.
Wang W; Xiao L; Pan D; Hu L
Neoplasma; 2022 Mar; 69(2):361-369. PubMed ID: 35103478
[TBL] [Abstract][Full Text] [Related]
9.
Noor H; Zaman A; Teo C; Sughrue ME
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830454
[TBL] [Abstract][Full Text] [Related]
10. The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma.
Fang L; Yu G; Yu W; Chen G; Ye B
PeerJ; 2021; 9():e12277. PubMed ID: 34707943
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on Microglia-Based Immune Therapies Against Glioblastoma.
Rivera M; Bander ED; Cisse B
World Neurosurg; 2021 Oct; 154():228-231. PubMed ID: 34583500
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.
Ma J; Han W; Lu K
Front Oncol; 2021; 11():711756. PubMed ID: 34490109
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
